How Sun Pharma Clinched Ranbaxy – The Inside Story
This article was originally published in The Pink Sheet Daily
Executive Summary
Sun Pharma’s Dilip Shanghvi bought out Ranbaxy to push ahead in the fast-evolving global generics industry. In contrast to wide speculation that the Ranbaxy deal was inked over a short time, bankers who spoke divulged a well-planned and studied move that began as early as in 2012 and culminated into the final agreement now.